Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.
Schmidt C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Howaldt S, Stallmach A, Büning C; AEGIS Study Group. Schmidt C, et al. Among authors: bokemeyer b. Aliment Pharmacol Ther. 2016 Aug;44(3):259-70. doi: 10.1111/apt.13665. Epub 2016 May 29. Aliment Pharmacol Ther. 2016. PMID: 27237709 Free PMC article. Clinical Trial.
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, Schulzke JD, Boerner N, Kueppers B, Emmrich J, Mescheder A, Schwertschlag U, Shapiro M, Stange EF. Herrlinger KR, et al. Among authors: bokemeyer b. Am J Gastroenterol. 2006 Apr;101(4):793-7. doi: 10.1111/j.1572-0241.2005.00356.x. Am J Gastroenterol. 2006. PMID: 16635225 Clinical Trial.
Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
Dignass AU, Bokemeyer B, Adamek H, Mross M, Vinter-Jensen L, Börner N, Silvennoinen J, Tan G, Pool MO, Stijnen T, Dietel P, Klugmann T, Vermeire S, Bhatt A, Veerman H. Dignass AU, et al. Among authors: bokemeyer b. Clin Gastroenterol Hepatol. 2009 Jul;7(7):762-9. doi: 10.1016/j.cgh.2009.04.004. Epub 2009 Apr 16. Clin Gastroenterol Hepatol. 2009. PMID: 19375519 Clinical Trial.
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D; Semapimod-CD04/CD05 Investigators. Dotan I, et al. Among authors: bokemeyer b. Gut. 2010 Jun;59(6):760-6. doi: 10.1136/gut.2009.179994. Gut. 2010. PMID: 20551461 Clinical Trial.
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C; FERGI Study Group. Evstatiev R, et al. Among authors: bokemeyer b. Gastroenterology. 2011 Sep;141(3):846-853.e1-2. doi: 10.1053/j.gastro.2011.06.005. Epub 2011 Jun 12. Gastroenterology. 2011. PMID: 21699794 Clinical Trial.
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.
Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J, Gasche C; FERGI Study Group. Evstatiev R, et al. Among authors: bokemeyer b. Clin Gastroenterol Hepatol. 2013 Mar;11(3):269-77. doi: 10.1016/j.cgh.2012.10.013. Epub 2012 Oct 16. Clin Gastroenterol Hepatol. 2013. PMID: 23078888 Clinical Trial.
Parameters of a severe disease course in ulcerative colitis.
Stallmach A, Nickel L, Lehmann T, Bokemeyer B, Bürger M, Hüppe D, Kruis W, Nikolaus S, Preiss JC, Sturm A, Teich N, Schmidt C. Stallmach A, et al. Among authors: bokemeyer b. World J Gastroenterol. 2014 Sep 21;20(35):12574-80. doi: 10.3748/wjg.v20.i35.12574. World J Gastroenterol. 2014. PMID: 25253960 Free PMC article.
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
Gasche C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Büning C, Howaldt S, Stallmach A; AEGIS Study Group. Gasche C, et al. Among authors: bokemeyer b. Inflamm Bowel Dis. 2015 Mar;21(3):579-88. doi: 10.1097/MIB.0000000000000314. Inflamm Bowel Dis. 2015. PMID: 25545376 Free PMC article. Clinical Trial.
130 results